Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 440, 603 (30 March 2006) | doi:10.1038/440603a; Published online 29 March 2006
Open Innovation Challenges
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Account Director -India
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Academic Neuropathologist
- University Hospitals Case Medical Center
- Cleveland, Ohio, USA
Too little, too late?
Abstract
Merger fever has finally reached Germany's drug firms. But can it cure the industry's woes? Alison Abbott reports.
Despite boasting an impressive historical heritage, Germany's once powerful pharmaceutical industry is now heavily fragmented. But the company that produced the world's first blockbuster drug is making a bid to reclaim some lost ground.
To read this story in full you will need to login or make a payment (see right).
